Pathology of Peripheral T-Cell Lymphomas: Where Do We Standα

Seminars in Hematology

Volumn 51, Issue 1, 2014, Pages 5-16

  Gaulard, Philippe ^a,b,c   de Leval, Laurence ^d  

^a HENRI MONDOR HOSPITAL   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c INSERM U955   (France)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; CD11B ANTIGEN; CD16 ANTIGEN; CD2 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45RO ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; GRANZYME; MAJOR HISTOCOMPATIBILITY ANTIGEN; NATURAL KILLER CELL RECEPTOR; PERFORIN; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR;

ALPHA BETA T LYMPHOCYTE; ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; ANTIGEN RECOGNITION; ARTICLE; BREAST IMPLANT; CANCER CLASSIFICATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SUBPOPULATION; CUTANEOUS T CELL LYMPHOMA; CYTOLOGY; CYTOTOXICITY; ENTEROPATHY ASSOCIATED T CELL LYMPHOMA; GAMMA DELTA T LYMPHOCYTE; HELPER CELL; HUMAN; LARGE CELL LYMPHOMA; LYMPHOCYTE PROLIFERATION; NATURAL KILLER T CELL; NK T CELL LYMPHOMA; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; T CELL LYMPHOMA; T LYMPHOCYTE;

ANIMALS; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL, PERIPHERAL; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; RECEPTOR PROTEIN-TYROSINE KINASES; T-LYMPHOCYTES;

EID: 84892882026     PISSN: 00371963     EISSN: 15328686     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2013.11.003     Document Type: Article

References (65)

1. Armitage J., Vose J., Weisenburger D. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 2008, 26:4124-4130.
2. Swerdlow S., Campo E., Harris N., et al. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, IARC Press, Lyon, France.
3. de Leval L., Rickman D.S., Thielen C., et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood 2007, 109:4952-4963.
4. Travert M., Huang Y., de Leval L., et al. Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets. Blood 2012, 119:5795-5806.
5. Garcia-Herrera A., Song J.Y., Chuang S.S., et al. Nonhepatosplenic gammadelta T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation. Am J Surg Pathol 2011, 35:1214-1225.
6. Savage K.J., Harris N.L., Vose J.M., et al. ALK-negative anaplastic large-cell lymphoma (ALCL) is clinically and immunophenotypically different from both ALK-positive ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. Blood 2008, 111:5496-5504.
7. Sibon D., Fournier M., Briere J., et al. Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trials. J Clin Oncol 2012, 30:3939-3946.
8. Lamant L., McCarthy K., d'Amore E., et al. Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study. J Clin Oncol 2011, 29:4669-4676.
9. + T-cell lymphoproliferations. Haematologica 2010, 10:1697-1704.
10. Bisig B., de Reynies A., Bonnet C., et al. CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features. Haematologica 2013, 98:1250-1258.
11. Lai R., Ingham R.J. The pathobiology of the oncogenic tyrosine kinase NPM-ALK: a brief update. Ther Adv Hematol 2013, 4:119-131.
12. Lamant L., Pileri S., Sabattini E., et al. Cutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: evidence for an association in five cases. Haematologica 2010, 95:449-455.
13. Agnelli L., Mereu E., Pellegrino E., et al. Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma. Blood 2012, 120:1274-1281.
14. Salaverria I., Bea S., Lopez-Guillermo A., et al. Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas. Br J Haematol 2008, 140:516-526.
15. + subtypes. Blood 2007, 109:2156-2164.
16. Piva R., Agnelli L., Pellegrino E., et al. Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms. J Clin Oncol 2010, 28:1583-1590.
17. Feldman A.L., Law M.E., Inwards D.J., et al. PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus. Mod Pathol 2010, 23:593-602.
18. Feldman A.L., Law M., Remstein E.D., et al. Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas. Leukemia 2009, 23:574-580.
19. Feldman A.L., Dogan A., Smith D.I., et al. Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing. Blood 2011, 117:915-919.
20. Sciallis A.P., Law M.E., Inwards D.J., et al. Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders. Mod Pathol 2012, 25:983-992.
21. Wada D.A., Law M.E., Hsi E.D., et al. Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies. Mod Pathol 2010, 24:596-605.
22. Oschlies I., Lisfeld J., Lamant L., et al. ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study. Haematologica 2013, 98:50-56.
23. Thompson P.A., Lade S., Webster H., et al. Effusion-associated anaplastic large cell lymphoma of the breast: time for it to be defined as a distinct clinico-pathological entity. Haematologica 2010, 95:1977-1979.
24. Aladily T.N., Medeiros L.J., Amin M.B., et al. Anaplastic large cell lymphoma associated with breast implants: a report of 13 cases. Am J Surg Pathol 2012, 36:1000-1008.
25. Gaulard P., de Leval L. Follicular helper T cells: implications in neoplastic hematopathology. Semin Diagn Pathol 2011, 28:202-213.
26. Iqbal J., Weisenburger D.D., Greiner T.C., et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood 2010, 115:1026-1036.
27. de Leval L., Gisselbrecht C., Gaulard P. Advances in the understanding and management of angioimmunoblastic T-cell lymphoma. Br J Haematol 2010, 148:673-689.
28. Bisig B., Thielen C., Herens C., et al. c-Maf expression in angioimmunoblastic T-cell lymphoma reflects follicular helper T-cell derivation rather than oncogenesis. Histopathology 2012, 60:371-376.
29. Attygalle A.D., Kyriakou C., Dupuis J., et al. Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression. Am J Surg Pathol 2007, 31:1077-1088.
30. Nicolae A., Pittaluga S., Venkataraman G., et al. Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist. Am J Surg Pathol 2013, 37:816-826.
31. Lemonnier F., Couronne L., Parrens M., et al. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters. Blood 2012, 120:1466-1469.
32. Cairns R.A., Iqbal J., Lemonnier F., et al. IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. Blood 2012, 119:1901-1903.
33. Couronne L., Bastard C., Bernard O.A. TET2 and DNMT3A mutations in human T-cell lymphoma. N Engl J Med 2012, 366:95-96.
34. Guo s., Kucuk C., Iqbal J., et al. Novel fusion transcripts identified in angioimmunoblastic T cell lymphoma. Mod Pathol 2013, 26:330A.
35. + phenotype. Am J Surg Pathol 2001, 25:395-400.
36. Huang Y., Moreau A., Dupuis J., et al. Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas. Am J Surg Pathol 2009, 33:682-690.
37. Moroch J., Copie-Bergman C., de Leval L., et al. Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics. Am J Surg Pathol 2012, 36:1636-1646.
38. Streubel B., Vinatzer U., Willheim M., et al. Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia 2006, 20:313-318.
39. Pechloff K., Holch J., Ferch U., et al. The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma. J Exp Med 2010, 207:1031-1044.
40. + small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers. Am J Surg Pathol 2009, 33:81-90.
41. Quintanilla-Martinez L., Jansen P.M., Kinney M.C., et al. Non-mycosis fungoides cutaneous T-cell lymphomas: report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop. Am J Clin Pathol 2013, 139:491-514.
42. Rodriguez-Pinilla S.M., Atienza L., Murillo C., et al. Peripheral T-cell lymphoma with follicular T-cell markers. Am J Surg Pathol 2008, 32:1787-1799.
43. Tripodo C., Iannitto E., Florena A.M., et al. Gamma-delta T-cell lymphomas. Nat Rev Clin Oncol 2009, 6:707-717.
44. Belhadj K., Reyes F., Farcet J.P., et al. Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 2003, 102:4261-4269.
45. Rodriguez-Pinilla S.M., Ortiz-Romero P.L., Monsalvez V., et al. TCR-gamma expression in primary cutaneous T-cell lymphomas. Am J Surg Pathol 2013, 37:375-384.
46. Arnulf B., Copie-Bergman C., Delfau-Larue M.H., et al. Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. Blood 1998, 91:1723-1731.
47. Au W.Y., Weisenburger D.D., Intragumtornchai T., et al. Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood 2009, 113:3931-3937.
48. Teruya-Feldstein J., Jaffe E.S., Burd P.R., et al. The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease. Blood 1997, 90:4099-4105.
49. Iqbal J., Kucuk C., Deleeuw R.J., et al. Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies. Leukemia 2009, 23:1139-1151.
50. Huang Y., de Reynies A., de Leval L., et al. Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type. Blood 2010, 115:1226-1237.
51. Coppo P., Gouilleux-Gruart V., Huang Y., et al. STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma. Leukemia 2009, 23:1667-1678.
52. Ferreri A.J., Zinzani P.L., Govi S., et al. Enteropathy-associated T-cell lymphoma. Crit Rev Oncol Hematol 2011, 79:84-90.
53. Attygalle A., Cabeçadas J., Gaulard P., et al. Peripheral T- and NK-cell lymphomas and their mimics: taking a step forward-report on the Lymphoma Workshop of the XVI meeting of the European Association for Haematopathology in Lisbon 2012. Histopathology 2014, 64:971-999.
54. Ashton-Key M., Diss T.C., Pan L., et al. Molecular analysis of T-cell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphoma. Am J Pathol 1997, 151:493-498.
55. Cellier C., Delabesse E., Helmer C., et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet 2000, 356:203-208.
56. Deleeuw R.J., Zettl A., Klinker E., et al. Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology 2007, 132:1902-1911.
57. Delabie J., Holte H., Vose J.M., et al. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project. Blood 2011, 118:148-155.
58. -T-cell lymphomas of monomorphic small to medium size histology. Am J Pathol 1998, 153:1483-1490.
59. Chan J.K., Chan A.C., Cheuk W., et al. Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent gammadelta T-cell receptor expression. Am J Surg Pathol 2011, 35:1557-1569.
60. Quintanilla-Martinez L., Fend F., Moguel L.R., et al. Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection. Am J Surg Pathol 1999, 23:1233-1240.
61. Dupuis J., Emile J.F., Mounier N., et al. Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: a Groupe d'Etude des Lymphomes de l'Adulte (GELA) study. Blood 2006, 108:4163-4169.
62. +) cytotoxic T-cells. Virchows Arch 2004, 445:334-343.
63. Asano N., Suzuki R., Kagami Y., et al. Clinicopathologic and prognostic significance of cytotoxic molecule expression in nodal peripheral T-cell lymphoma, unspecified. Am J Surg Pathol 2005, 29:1284-1293.
64. Bisig B., Gaulard P., de Leval L. New biomarkers in T-cell lymphomas. Best Pract Res Clin Haematol 2012, 25:13-28.
65. Vasmatzis G., Johnson S.H., Knudson R.A., et al. Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas. Blood 2012, 120:2280-2289.